Braun-Bostich & Associates’s Amgen AMGN Stock Holding History

Braun-Bostich & Associates’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,066	Closed	-$271K	–	70
2020 Q3	$271K	Sell	1,066 -1,111	-51%	-$275K	0.27%	58
2020 Q2	$513K	Hold	2,177	–	–	0.5%	30
2020 Q1	$431K	Sell	2,177 -208	-9%	-$45.4K	0.55%	37
2019 Q4	$573K	Buy	2,385 +139	+6%	+$30.6K	0.56%	33
2019 Q3	$435K	Buy	2,246 +331	+17%	+$63.5K	0.51%	40
2019 Q2	$353K	Buy	1,915 +697	+57%	+$125K	0.37%	51
2019 Q1	$231K	Buy	1,218 +878	+258%	+$168K	0.24%	90
2018 Q4	$66K	Hold	340	–	–	0.07%	160
2018 Q3	$70K	Sell	340 -127	-27%	-$25K	0.07%	160
2018 Q2	$86K	Sell	467 -194	-29%	-$34.3K	0.09%	149
2018 Q1	$113K	Sell	661 -1,355	-67%	-$249K	0.1%	123
2017 Q4	$351K	Buy	+2,016	New	+$357K	0.3%	95

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Braun-Bostich & Associates's AMGN Position: Q4 2020 in Review

Braun-Bostich & Associates sold out of Amgen (AMGN) in Q4 2020, closing a stake of 1,066 shares — an estimated $271K sold.

Braun-Bostich & Associates first reported a position in AMGN in Q4 2017 and held it in 12 quarters. The position peaked at $573K in Q4 2019. 2,218 funds tracked by Wall St. Rank hold AMGN as of Q4 2020.

Braun-Bostich & Associates reported no remaining Amgen position as of Q4 2020 after selling out during the quarter.
Braun-Bostich & Associates sold 1,066 Amgen shares in Q4 2020, an estimated $271K.
Braun-Bostich & Associates first reported a position in Amgen in Q4 2017 and held it in 12 quarters.
Braun-Bostich & Associates's Amgen position peaked at $573K in Q4 2019.
2,218 funds tracked by Wall St. Rank held Amgen as of Q4 2020.

Based on Braun-Bostich & Associates's 13F filing for Q4 2020, filed 16 Feb 2021.